Rochelle Collantes, MD, MPH Research Associate, Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA
Janus P. Ong, MD Staff Hepatologist, Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA
Zobair M. Younossi, MD, MPH Director, Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA
Address: Zobair M. Younossi, MD, MPH, Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042-3300
This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTNonalcoholic fatty liver disease (NAFLD) is common in patients with the metabolic syndrome, and it is expected to become more common in countries where obesity, one of the components of the metabolic syndrome, is increasing.
